FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Track all the latest updates and news of GreenSignal Bio Pharma IPO.
April 23, 2024 7:30:15 PM
Biotech IPOs surged at the start of 2024, but the rest of the year will depend on Fed rate cuts. Meanwhile, doctors using VR and AI to hone their skills.
Published by : CNBC on MSNApril 22, 2024 12:53:00 PM
Mergers and acquisitions are on the rise in 2024, sending a hopeful sign for the recovery of the life sciences market. Check out the deals with ties to Massachusetts.
Published by : The Business JournalsApril 12, 2024 3:30:00 AM
Today the City bank launches an �IPO speedometer� to give �a numerical score (0-60mph) for the health of the UK IPO market.� The speedometer indicates whether the window is open in ...
Published by : The Financial TimesMarch 28, 2024 10:40:00 AM
Boundless Bio is bringing in $100 million from its IPO as the precision oncology company becomes the latest biotech to go public in 2024. The company has priced its 6.25 million shares at $16 ...
Published by : FierceBiotechApril 9, 2024 3:30:00 AM
In 2023, biopharma financings averaged $5.91 billion per month. March brought two biopharma IPOs, totaling $2.65 billion, driven by Galderma Group AG�s inaugural offering of more than $2 billion.
Published by : BioWorldApril 19, 2024 6:30:00 PM
The company raised around $200 million in its IPO, despite the overall size being $600 million. Ibotta is a profitable digital marketing company that allows consumer packaged goods companies to ...
Published by : Seeking AlphaMarch 23, 2024 6:40:00 AM
Shares of the social media company soared on its Big Board debut under the ticker RDDT, closing at $50.44, or 48 percent above its IPO price. This brought its fully diluted market capitalization ...
Published by : Ars TechnicaApril 18, 2024 8:32:00 PM
Ibotta Inc. climbed 17% in its trading debut after the digital marketing software firm and a group of shareholders raised about $577.3 million in an initial public offering priced above a marketed ...
Published by : Bloomberg L.P.April 16, 2024 5:50:00 PM
On December 4, 2023, Southwest Gas Holdings, Inc. announced its plan to pursue an initial public offering (IPO) of Centuri Holdings. On March 22, 2024, Centuri Holdings, Inc. (Utility ...
Published by : ForbesApril 10, 2024 11:30:00 AM
The Japanese owner of 7-Eleven, Seven & i Holdings, is considering listing its superstore business as part of efforts to focus on its convenience-store segment. The company, which also owns other ...
Published by : Wall Street JournalMarch 29, 2024 1:40:00 AM
ArriVent BioPharma, Inc. press release (NASDAQ:AVBP): FY net loss was $69.3 million. Research and development expenses were $64.9 million. General and administrative expenses were $9.7 million.
Published by : Seeking AlphaGreenSignal Bio Pharma Ltd IPO to open on Nov 09, 2016 and close for subscription on Nov 22, 2016. The price band for the issue has been fixed at Rs 68 at lower level and Rs 76 at upper level. The equity shares of the company to be list at BSE and NSE.
GreenSignal Bio Pharma Ltd is entering in the capital markets with an initial public offering, IPO of 14,579,560 Equity Shares of Rs 10. The price band for the issue has been fixed at Rs 68 at lower level and Rs 76 at upper level.
GreenSignal Bio Pharma is Chennai based pharmaceutical company engaged in the development, manufacture and sale of the BCG vaccine. source chittorgarh.com, India's No. 1 IPO Investment Portal. GreenSignal is an Indian vaccine manufacturing company with global operations. The products company manufacture includes a BCG vaccine and BCG-ONCO, an immunotherapy drug. The immunotherapy drug is used in the treatment of urinary bladder cancer.
The issue opens on Nov 09, 2016 and closes for subscription on Nov 22, 2016. The equity shares of the issue are proposed to be list on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
The GreenSignal Bio Pharma IPO is proposed to open on November 9, 2016. The IPO application ends on November 22, 2016.
Retail investors can apply in the retail or non-institutional investor category from November 9, 2016 to November 22, 2016. The GreenSignal Bio Pharma IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The GreenSignal Bio Pharma IPO will open for subscription on November 9, 2016. The public issue will close on November 22, 2016.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|